Activation of liver X receptors attenuates endotoxin-induced liver injury in mice with nonalcoholic fatty liver disease

Digestive Diseases and Sciences

Volumn 57, Issue 2, 2012, Pages 390-398

  Liu, Yuan ^a   Han, Xiaofeng ^a   Bian, Zhaolian ^a   Peng, Yanshen ^a   You, Zhengrui ^a   Wang, Qixia ^a   Chen, Xiaoyu ^a   Qiu, Dekai ^a   Ma, Xiong ^a  

^a SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

Author keywords

Cholesterol; Inducible NOS; Inflammation; Macrophage; Nonalcoholic steatohepatitis

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; ENDOTOXIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INDUCIBLE NITRIC OXIDE SYNTHASE; LIPOPOLYSACCHARIDE; LIVER X RECEPTOR; MITOGEN ACTIVATED PROTEIN KINASE; N (2,2,2 TRIFLUOROETHYL) N [4 [2,2,2 TRIFLUORO 1 HYDROXY 1 (TRIFLUOROMETHOXY)ETHYL]PHENYL]BENZENESULFONAMIDE; PHOSPHATIDYLINOSITOL 3 KINASE; STRESS ACTIVATED PROTEIN KINASE; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BONE MARROW DERIVED MACROPHAGE; CELL ISOLATION; CONTROLLED STUDY; DRUG EFFECT; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; IN VIVO STUDY; LIPID DIET; LIVER HISTOLOGY; LIVER INJURY; MACROPHAGE; MALE; MOUSE; NONALCOHOLIC FATTY LIVER; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; WESTERN BLOTTING; WILD TYPE;

ALANINE TRANSAMINASE; ANIMALS; ASPARTATE AMINOTRANSFERASES; BLOTTING, WESTERN; FATTY LIVER; HYDROCARBONS, FLUORINATED; IMMUNOHISTOCHEMISTRY; LIPOGENESIS; LIPOPOLYSACCHARIDES; LIVER; MALE; MICE; MICE, INBRED C57BL; MITOGEN-ACTIVATED PROTEIN KINASES; NF-KAPPA B; NITRIC OXIDE SYNTHASE TYPE II; ORPHAN NUCLEAR RECEPTORS; SULFONAMIDES; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84856760156     PISSN: 01632116     EISSN: 15732568     Source Type: Journal    
DOI: 10.1007/s10620-011-1902-9     Document Type: Article

References (35)

1. P Angulo 2002 Nonalcoholic fatty liver disease N Engl J Med 346 1221 1231 11961152 10.1056/NEJMra011775 1:CAS:528:DC%2BD38XivVOmsrY%3D (Pubitemid 34984585)
2. EM Brunt 2007 Pathology of fatty liver disease Mod Pathol 20 S40 S48 17486051 10.1038/modpathol.3800680 1:CAS:528:DC%2BD2sXkvFKit7k%3D (Pubitemid 46733652)
3. DG Tiniakos MB Vos EM Brunt 2010 Nonalcoholic fatty liver disease: pathology and pathogenesis Annu Rev Pathol 5 145 171 20078219 10.1146/annurev-pathol-121808-102132 1:CAS:528:DC%2BC3cXivFekt7s%3D
4. F Marra 2008 Nuclear factor-kappaB inhibition and non-alcoholic steatohepatitis: inflammation as a target for therapy Gut 57 570 572 18408098 10.1136/gut.2007.141986 1:CAS:528:DC%2BD1cXmt1antLg%3D (Pubitemid 351579965)
5. Y Kodama DA Brenner 2009 c-Jun N-terminal kinase signaling in the pathogenesis of nonalcoholic fatty liver disease: multiple roles in multiple steps Hepatology 49 6 8 19111006 10.1002/hep.22710 1:CAS:528: DC%2BD1MXhsFGlt74%3D
6. JJ Repa DJ Mangelsdorf 2000 The role of orphan nuclear receptors in the regulation of cholesterol homeostasis Annu Rev Cell Dev Biol 16 459 481 11031244 10.1146/annurev.cellbio.16.1.459 1:CAS:528:DC%2BD3MXpvFyl (Pubitemid 32037514)
7. BA Janowski PJ Willy TR Devi JR Falck DJ Mangelsdorf 1996 An oxysterol signalling pathway mediated by the nuclear receptor LXR alpha Nature 383 728 731 8878485 10.1038/383728a0 1:CAS:528:DyaK28XmsVGns78%3D (Pubitemid 26360651)
8. JM Lehmann SA Kliewer LB Moore TA Smith-Oliver BB Oliver JL Su SS Sundseth, et al. 1997 Activation of the nuclear receptor LXR by oxysterols defines a new hormone response pathway J Biol Chem 272 3137 3140 9013544 10.1074/jbc.272.6.3137 1:CAS:528:DyaK2sXhtFenu7o%3D (Pubitemid 27066798)
9. BA Janowski MJ Grogan SA Jones GB Wisely SA Kliewer EJ Corey DJ Mangelsdorf 1999 Structural requirements of ligands for the oxysterol liver X receptors LXRalpha and LXRbeta Proc Natl Acad Sci USA 96 266 271 9874807 10.1073/pnas.96.1.266 1:CAS:528:DyaK1MXjvV2gtw%3D%3D (Pubitemid 29036088)
10. N Higuchi M Kato Y Shundo H Tajiri M Tanaka N Yamashita M Kohjima, et al. 2008 Liver X receptor in cooperation with SREBP-1c is a major lipid synthesis regulator in nonalcoholic fatty liver disease Hepatol Res 38 1122 1129 18684130 10.1111/j.1872-034X.2008.00382.x 1:CAS:528:DC%2BD1cXhsVWju7zL
11. JY Cha JJ Repa 2007 The liver X receptor (LXR) and hepatic lipogenesis. The carbohydrate-response element-binding protein is a target gene of LXR J Biol Chem 282 743 751 17107947 10.1074/jbc.M605023200 1:CAS:528:DC%2BD2sXkslCi (Pubitemid 47076632)
12. AE Myhre J Agren MK Dahle MV Tamburstuen SP Lyngstadaas AJ Collins SJ Foster, et al. 2008 Liver X receptor is a key regulator of cytokine release in human monocytes Shock 29 468 474 17724434 1:CAS:528:DC%2BD1cXkvVarsrY%3D (Pubitemid 351416800)
13. YY Wang MK Dahle J Agren AE Myhre FP Reinholt SJ Foster JL Collins, et al. 2006 Activation of the liver X receptor protects against hepatic injury in endotoxemia by suppressing Kupffer cell activation Shock 25 141 146 16525352 10.1097/01.shk.0000191377.78144.d9 1:CAS:528:DC%2BD28XhslantLo%3D
14. J Xu G Wagoner JC Douglas PD Drew 2009 Liver X receptor agonist regulation of Th17 lymphocyte function in autoimmunity J Leukoc Biol 86 401 409 19406833 10.1189/jlb.1008600 1:CAS:528:DC%2BD1MXps1elsrg%3D
15. X Ma J Hua Z Li 2008 Probiotics improve high-fat diet-induced hepatic steatosis and insulin resistance by increasing hepatic NKT cells J Hepatol 49 821 830 18674841 10.1016/j.jhep.2008.05.025 1:CAS:528:DC%2BD1cXht1eju7fL
16. H Tilg 2010 The role of cytokines in non-alcoholic fatty liver disease Dig Dis 28 179 185 20460908 10.1159/000282083
17. Z Li S Yang H Lin J Huang PA Watkins AB Moser C Desimone, et al. 2003 Probiotics and antibodies to TNF inhibit inflammatory activity and improve nonalcoholic fatty liver disease Hepatology 37 343 350 12540784 10.1053/jhep.2003.50048 1:CAS:528:DC%2BD3sXhsFeltr4%3D (Pubitemid 36152533)
18. E Hatano BL Bennett AM Manning T Qian JJ Lemasters DA Brenner 2001 NF-kappaB stimulates inducible nitric oxide synthase to protect mouse hepatocytes from TNF-alpha- and Fas-mediated apoptosis Gastroenterology 120 1251 1262 11266388 10.1053/gast.2001.23239 1:CAS:528:DC%2BD3MXjtVeqsbk%3D (Pubitemid 32246677)
19. H Tilg GS Hotamisligil 2006 Nonalcoholic fatty liver disease: cytokine-adipokine interplay and regulation of insulin resistance Gastroenterology 131 934 945 16952562 10.1053/j.gastro.2006.05.054 1:CAS:528:DC%2BD28XhtVKrurbP (Pubitemid 44307061)
20. H Malhi GJ Gores 2008 Molecular mechanisms of lipotoxicity in nonalcoholic fatty liver disease Semin Liver Dis 28 360 369 18956292 10.1055/s-0028-1091980 1:CAS:528:DC%2BD1cXhsVKju7fF
21. K Sakai H Suzuki H Oda T Akaike Y Azuma T Murakami K Sugi, et al. 2006 Phosphoinositide 3-kinase in nitric oxide synthesis in macrophage: critical dimerization of inducible nitric-oxide synthase J Biol Chem 281 17736 17742 16636057 10.1074/jbc.M601896200 1:CAS:528:DC%2BD28XmtFyksb0%3D (Pubitemid 44035572)
22. G Baffy 2009 Kupffer cells in non-alcoholic fatty liver disease: the emerging view J Hepatol 51 212 223 19447517 10.1016/j.jhep.2009.03.008 1:CAS:528:DC%2BD1MXntVKgu74%3D
23. K Tomita G Tamiya S Ando K Ohsumi T Chiyo A Mizutani N Kitamura, et al. 2006 Tumour necrosis factor alpha signalling through activation of Kupffer cells plays an essential role in liver fibrosis of non-alcoholic steatohepatitis in mice Gut 55 415 424 16174657 10.1136/gut.2005.071118 1:CAS:528: DC%2BD28Xis1Sjtrk%3D (Pubitemid 43268283)
24. SB Joseph A Castrillo BA Laffitte DJ Mangelsdorf P Tontonoz 2003 Reciprocal regulation of inflammation and lipid metabolism by liver X receptors Nat Med 9 213 219 12524534 10.1038/nm820 1:CAS:528:DC%2BD3sXotlSgsw%3D%3D (Pubitemid 36227724)
25. S Ogawa J Lozach C Benner G Pascual RK Tangirala S Westin A Hoffmann, et al. 2005 Molecular determinants of crosstalk between nuclear receptors and Toll-like receptors Cell 122 707 721 16143103 10.1016/j.cell.2005.06.029 1:CAS:528:DC%2BD2MXhtVaqu73P (Pubitemid 41242636)
26. A Mantovani A Sica M Locati 2005 Macrophage polarization comes of age Immunity 23 344 346 16226499 10.1016/j.immuni.2005.10.001 1:CAS:528: DC%2BD2MXht1Shs77O (Pubitemid 41443435)
27. A Grefhorst BM Elzinga PJ Voshol T Plosch T Kok VW Bloks FH van der Sluijs, et al. 2002 Stimulation of lipogenesis by pharmacological activation of the liver X receptor leads to production of large, triglyceride-rich very low density lipoprotein particles J Biol Chem 277 34182 34190 12097330 10.1074/jbc.M204887200 1:CAS:528:DC%2BD38Xnt1SqtL8%3D
28. K Wouters M van Bilsen PJ van Gorp V Bieghs D Lutjohann A Kerksiek B Staels, et al. 2010 Intrahepatic cholesterol influences progression, inhibition and reversal of non-alcoholic steatohepatitis in hyperlipidemic mice FEBS Lett 584 1001 1005 20114046 10.1016/j.febslet.2010.01.046 1:CAS:528: DC%2BC3cXit1OlsLc%3D
29. K Wouters PJ van Gorp V Bieghs MJ Gijbels H Duimel D Lutjohann A Kerksiek, et al. 2008 Dietary cholesterol, rather than liver steatosis, leads to hepatic inflammation in hyperlipidemic mouse models of nonalcoholic steatohepatitis Hepatology 48 474 486 18666236 10.1002/hep.22363
30. K Yamaguchi L Yang S McCall J Huang XX Yu SK Pandey S Bhanot, et al. 2007 Inhibiting triglyceride synthesis improves hepatic steatosis but exacerbates liver damage and fibrosis in obese mice with nonalcoholic steatohepatitis Hepatology 45 1366 1374 17476695 10.1002/hep.21655 1:CAS:528: DC%2BD2sXnvFaltLw%3D (Pubitemid 46918320)
31. SS Choi AM Diehl 2008 Hepatic triglyceride synthesis and nonalcoholic fatty liver disease Curr Opin Lipidol 19 295 300 18460922 10.1097/MOL. 0b013e3282ff5e55 1:CAS:528:DC%2BD1cXlsV2rtbc%3D (Pubitemid 351653569)
32. SW Beaven K Wroblewski J Wang C Hong S Bensinger H Tsukamoto P Tontonoz 2011 Liver X receptor signaling is a determinant of stellate cell activation and susceptibility to fibrotic liver disease Gastroenterology 140 1052 1062 21134374 10.1053/j.gastro.2010.11.053 1:CAS:528:DC%2BC3MXjs1Wks74%3D
33. SE McKim E Gabele F Isayama JC Lambert LM Tucker MD Wheeler HD Connor, et al. 2003 Inducible nitric oxide synthase is required in alcohol-induced liver injury: studies with knockout mice Gastroenterology 125 1834 1844 14724835 10.1053/j.gastro.2003.08.030 1:CAS:528:DC%2BD2cXhtVOqtQ%3D%3D (Pubitemid 37500447)
34. A Venkatraman S Shiva A Wigley E Ulasova D Chhieng SM Bailey VM Darley-Usmar 2004 The role of iNOS in alcohol-dependent hepatotoxicity and mitochondrial dysfunction in mice Hepatology 40 565 573 15349894 10.1002/hep.20326 1:CAS:528:DC%2BD2cXot1Ortrs%3D (Pubitemid 39265577)
35. A Spruss G Kanuri K Uebel SC Bischoff I Bergheim 2011 Role of the inducible nitric oxide synthase (iNOS) in the onset of fructose-induced steatosis in mice Antioxid Redox Signal 14 2121 2135 21083420 10.1089/ars.2010.3263 1:CAS:528:DC%2BC3MXlvFOisLw%3D